Organoids, spheroids, co-culture systems, human tissue workflows and tissue-engineered platforms are becoming essential tools for evaluating treatment response.
The quality of translational research depends heavily on the quality of the model.
Traditional systems often fail to capture the complexity of human disease biology, especially in cancers shaped by fibrosis, immune regulation, stromal resistance and tissue architecture.
Imperion’s platform direction includes organoids, spheroids, primary co-culture systems, human tissue workflows and tissue-engineered models to support more physiologically relevant evaluation of disease mechanisms and treatment response.